Heart Disease Trial, Recruiting NCT06874556 Sponsor: Mayo Clinic Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06874556
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults who have been admitted to hospital with worsening heart failure and who may be ready to go home early with the support of a care programme and regular monitoring.
  • People with suddenly worsening heart failure who are at home or being seen in an outpatient clinic and need large amounts of fluid-removing medication (diuretics), but whose condition does not require full hospital-level care.
  • People with advanced, severe heart failure (known as Stage D) who need their fluid-removing medication adjusted frequently — more than once a week — whether they are currently in hospital or being seen as an outpatient.

Who may not be able to join:

  • People whose condition requires the level of monitoring and care that only a hospital can provide.
  • People who do not pass a safety assessment, are currently struggling with substance use, or have a mental health diagnosis that could affect their ability to take part.
  • People who are currently enrolled in hospice care.
  • People who are living in a skilled nursing facility.
  • People who do not have a primary care doctor or a heart specialist (cardiologist) at Mayo Clinic.
  • People who have difficulty communicating due to a medical condition or problems with memory and thinking.
  • People who are pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sara Severson, APRN, C.N.P., Mayo Clinic

Phone: 507-266-2328

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
24 June 2025
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of Days without Hospitalization; Number of Days in the Hospital; Number of Emergency Department (ED) Visits; Number of Hospitalizations; Minnesota Living with Heart Failure Questionnaire (MLHFQ); Number of patients to comply with the guideline-directed medical therapy (GDMT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov